AVITA Medical Gets CE Mark Approval for RECELL GO

MT Newswires Live
09/15

AVITA Medical (RCEL) said Sunday that it has received CE Mark approval for its RECELL GO device, enabling it to commence sales in Europe and other CE-marked markets.

The company said that it will now roll out the device in select European countries, including Germany, Italy, and the UK, in collaboration with burn centers and clinical partners.

RECELL GO helps doctors use a small sample of a patient's skin to create a cell suspension that promotes healing in burns and wounds, it added.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10